Related Experiment Videos
Radioiodinated tracers for myocardial imaging
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas 75235-9058.
Seminars in Nuclear Medicine
|April 1, 1990
Summary
New radioiodine (123I) radiopharmaceuticals offer advanced cardiac imaging for metabolism, neuronal activity, and receptor concentration. Improved production and labeling techniques enhance clinical applications for myocardial assessment.
Area of Science:
- Nuclear medicine
- Radiopharmaceutical chemistry
- Cardiovascular imaging
Background:
- Advances in radioiodine (123I) production and radiolabeling techniques enable new cardiovascular radiopharmaceuticals.
- 123I-labeled agents are being developed for myocardial metabolism, neuronal activity, necrosis, and receptor imaging.
- Existing imaging applications include blood pool ventriculography, perfusion, and infarct-avid imaging.
Purpose of the Study:
- To discuss developments in radioiodine (123I)-labeled radiotracers for myocardial imaging.
- To highlight the potential of 123I-labeled agents in assessing myocardial metabolism, neuronal activity, and receptor concentration.
- To review the advantages and limitations of using 123I in radiopharmaceuticals.
Main Methods:
- Review of recent advances in the production of high-purity radioiodine (123I).
- Discussion of new efficient radiolabeling techniques for cardiovascular radiopharmaceuticals.
- Analysis of the properties and applications of various 123I-labeled molecules, including fatty acids, MIBG, monoclonal antibodies, and receptor binding agents.
Main Results:
- 123I-labeled fatty acids and MIBG show encouraging results in clinical investigations for myocardial metabolism and neuronal activity.
- 123I- and 111In-labeled antibody fragments are used for imaging myocardial necrosis.
- Development of radiotracers for cholinergic and adrenergic receptors is ongoing.
- Recent production improvements have reduced undesirable radionuclidic impurities in 123I.
Conclusions:
- Developments in 123I-labeled agents are crucial for assessing myocardial metabolism, neuronal activity, and receptor concentration.
- Improved production and availability of pure 123I at a modest cost will enhance clinical applications.
- 123I possesses nearly ideal nuclear properties for nuclear medicine, making it well-suited for labeling biomolecules.
- 123I-labeled radiotracers hold significant promise for advancing cardiac imaging.